Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Qing-Rui Li"'
Autor:
Zhuang Li, Wen-Juan Fu, Xiao-Qing Chen, Shuai Wang, Ru-Song Deng, Xiao-Peng Tang, Kai-Di Yang, Qin Niu, Hong Zhou, Qing-Rui Li, Yong Lin, Mei Liang, Si-Si Li, Yi-Fang Ping, Xin-Dong Liu, Xiu-Wu Bian, Xiao-Hong Yao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-20 (2022)
Abstract Background Glioblastoma (GB) is the most common and highly malignant brain tumor characterized by aggressive growth and resistance to alkylating chemotherapy. Autophagy induction is one of the hallmark effects of anti-GB therapies with temoz
Externí odkaz:
https://doaj.org/article/202a414ee63146bebbe58aa60f445ecf
Autor:
Jun-Hai Tang, Lin Yang, Ju-Xiang Chen, Qing-Rui Li, Li-Rong Zhu, Qing-Fu Xu, Guo-Hao Huang, Zuo-Xin Zhang, Yan Xiang, Lei Du, Zheng Zhou, Sheng-Qing Lv
Publikováno v:
Cancer Communications, Vol 39, Iss 1, Pp 1-16 (2019)
Abstract Background High-grade glioma (HGG) is a fatal human cancer. Bortezomib, a proteasome inhibitor, has been approved for the treatment of multiple myeloma but its use in glioma awaits further investigation. This study aimed to explore the chemo
Externí odkaz:
https://doaj.org/article/fda4699c7c214c308696ae6f906b82e9
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling
Autor:
Cong Chen, Wen Yin, Min Luo, Yan Wang, Ling-Xiang Wu, Hai-Tao Guo, Yi-Fang Ping, Chun-Hua Luo, Wei Chen, Yu-Qi Liu, Lin-Rong Che, Zhong-yi Qin, Tian-Ran Li, Qianghu Wang, Shuang Wang, Chao Wang, Kaidi Yang, Zhi-Cheng He, Sheng-Qing Lv, Wen-Ying Wang, Hua Feng, Bin Wang, Xiao-Ning Zhang, Min Mao, Yu Shi, Yaoyao Tan, Qing-Rui Li, Xiu-Wu Bian, Qing Liu
Publikováno v:
Cell Research
Glioblastoma (GBM) is a prevalent and highly lethal form of glioma, with rapid tumor progression and frequent recurrence. Excessive outgrowth of pericytes in GBM governs the ecology of the perivascular niche, but their function in mediating chemoresi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be4dc8ead944b0b7e66f331db8aab92
http://europepmc.org/articles/PMC8486800
http://europepmc.org/articles/PMC8486800
Autor:
Lei Zhang, Qing-Rui Li, Ru-fu Xu, Dong Zhang, Junhao Hu, Li Wen, Jian-Ping Xu, Sheng-Qing Lv, Yang Liuqing
Publikováno v:
Academic Radiology. 28:e137-e146
To investigate the performance of multi-parametric magnetic resonance imaging (MRI) for glioma grading.Seventy consecutive patients with histopathologically confirmed glioma were retrospectively evaluated by conventional MRI, dynamic susceptibility-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::986fa7f0dc9112621553d2d59717b386
https://doi.org/10.1016/j.acra.2020.03.035
https://doi.org/10.1016/j.acra.2020.03.035
Autor:
Zhuang Li, Wen-Juan Fu, Xiao-Qing Chen, Shuai Wang, Ru-Song Deng, Xiao-Peng Tang, Kai-Di Yang, Qin Niu, Hong Zhou, Qing-Rui Li, Yong Lin, Mei Liang, Si-Si Li, Yi-Fang Ping, Xin-Dong Liu, Xiu-Wu Bian, Xiao-Hong Yao
Publikováno v:
Journal of experimentalclinical cancer research : CR. 41(1)
Background Glioblastoma (GB) is the most common and highly malignant brain tumor characterized by aggressive growth and resistance to alkylating chemotherapy. Autophagy induction is one of the hallmark effects of anti-GB therapies with temozolomide (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8021ec6992de85c53e7979eada6e373c
https://pubmed.ncbi.nlm.nih.gov/35193644
https://pubmed.ncbi.nlm.nih.gov/35193644
Autor:
Sheng-Qing Lv, Zhen Fu, Lin Yang, Qing-Rui Li, Jiang Zhu, Qu-Jing Gai, Min Mao, Jiang He, Yan Qin, Xiao-Xue Yao, Xi Lan, Yan-Xia Wang, Hui-Min Lu, Yan Xiang, Zuo-Xin Zhang, Guo-Hao Huang, Wei Yang, Ping Kang, Zhijian Sun, Yu Shi, Xiao-Hong Yao, Xiu-Wu Bian, Yan Wang
Publikováno v:
Theranostics
Rationale: Around 10%-20% patients with glioblastoma (GBM) are diagnosed with more than one tumor lesions or multifocal GBM (mGBM). However, the understanding on genetic, DNA methylomic, and transcriptomic characteristics of mGBM is still limited. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::807296691d218562a8ebaabba8f3f346
https://pubmed.ncbi.nlm.nih.gov/34987659
https://pubmed.ncbi.nlm.nih.gov/34987659
Publikováno v:
Cellular and Molecular Neurobiology. 39:871-882
Lipopolysaccharide-induced tumor necrosis factor alpha factor (LITAF), also called p53-induced gene 7 (PIG7), was identified as a transcription factor that activates transcription of proinflammatory cytokines in macrophages in response to lipopolysac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5769c0b0e52d8600ee95172f8cc903ef
https://doi.org/10.1007/s10571-019-00686-4
https://doi.org/10.1007/s10571-019-00686-4
Autor:
Jun-Hai Tang, Sheng-Qing Lv, Wu Xu, Guo-Qing Hu, Qing-Rui Li, Clive Da Costa, Ya-Wen Pan, Lei Du
Publikováno v:
OncoTargets and Therapy. 12:3467-3480
Introduction: Brain glioma is the most common type of primary malignancy in the central nervous system (CNS), with high recurrence and mortality rate, especially glioblastoma (GBM). Recent evidence suggests a role for many long noncoding RNAs (lncRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::481a3db32c279a213aad6c456c75d829
https://doi.org/10.2147/ott.s201732
https://doi.org/10.2147/ott.s201732
Autor:
Lin Yang, Zheng Zhou, Sheng-Qing Lv, Qing-Fu Xu, Jun-Hai Tang, Zuo-Xin Zhang, Ju-Xiang Chen, Qing-Rui Li, Yan Xiang, Li-Rong Zhu, Guo-Hao Huang, Lei Du
Publikováno v:
Cancer Communications, Vol 39, Iss 1, Pp 1-16 (2019)
Cancer Communications
Cancer Communications
Background High-grade glioma (HGG) is a fatal human cancer. Bortezomib, a proteasome inhibitor, has been approved for the treatment of multiple myeloma but its use in glioma awaits further investigation. This study aimed to explore the chemotherapeut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c46664e84a4cb1655c22d7551f4d7c
https://doi.org/10.1186/s40880-019-0424-2
https://doi.org/10.1186/s40880-019-0424-2
Autor:
Sheng-Qing Lv, Zhen Fu, Lin Yang, Qing-Rui Li, Jiang Zhu, Qu-Jing Gai, Min Mao, Jiang He, Yan Qin, Xiao-Xue Yao, Xi Lan, Yan-Xia Wang, Hui-Min Lu, Yan Xiang, Zuo-Xin Zhang, Guo-Hao Huang, Wei Yang, Ping Kang, Zhijian Sun, Yu Shi
Publikováno v:
Theranostics; 2022, Vol. 12 Issue 1, p459-473, 15p